Europe Hemoglobinopathies Market: Deep Dive into Trends | 2032
The hemoglobinopathies market in Europe is experiencing significant growth, with a market valuation of USD 6.9 billion in 2023. Europe is a key player in the global market, driven by the increasing prevalence of thalassemia and sickle cell anemia. With an impressive CAGR of 9.7%
